Document Detail


Early transvaginal embryo aspiration: a safer method for selective reduction in high order multiple gestations.
MedLine Citation:
PMID:  10402409     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Assisted reproduction technologies and ovulation induction for treatment of infertility continue to cause high order multiple gestations. Increased perinatal morbidity and mortality, as well as maternal morbidity, may complicate these pregnancies. Selective fetal reduction, an acceptable therapeutic approach in these cases, is usually performed at or after the ninth week of gestation, with KCl injected in the vicinity of the fetal heart, and is associated with a total pregnancy loss rate of 11.7%. We report our experience with 90 women who underwent early (mean 7.5 weeks gestation, range 7. 0-8.0 weeks) transvaginal selective embryo aspiration. The mean number of viable embryos before and after reduction was 3.5 and 2.1 respectively. Six (6.7%) pregnancies were lost before 24 gestational weeks. One miscarriage occurred at the tenth gestational week. The other five pregnancies were aborted at 17.3-21.6 weeks gestation. Additional interventions were performed in three of these pregnancies: genetic amniocentesis in two cases and cervical suture in one case. In the subset of 39 patients with>/=4 embryos, only one (2.6%) pregnancy loss was recorded. This loss rate is significantly lower (P < 0.05) than the 15.3% loss rate in patients with >/=4 fetuses calculated from other work. Four (4.4%) other pregnancies were complicated by premature delivery (25-28 weeks gestation). Mean gestational age of delivered pregnancies in our series was 35.7 weeks. In conclusion, early transvaginal embryo aspiration is a simple and relatively safe method for multiple pregnancy reduction. The overall pregnancy loss rate associated with early embryo aspiration is similar to that of procedures performed at later gestational age, but is significantly lower when the initial number of embryos is four or greater.
Authors:
M S Coffler; S Kol; A Drugan; J Itskovitz-Eldor
Related Documents :
12696789 - Selective reduction.
17295349 - Midtrimester maternal serum inhibin a levels after multifetal pregnancy reduction.
12643519 - Triplet pregnancies and their aftermaths ii. risks of older mothers and plurality.
19005259 - Mirror syndrome associated with hydropic acardius in triplet pregnancy.
25074749 - Antenatal breast milk expression by women with diabetes for improving infant outcomes.
4050299 - Triplet gestation: maternal and neonatal implications.
23600369 - Overexpression of cd39 protects in a mouse model of preeclampsia.
15117289 - Psychosocial predictors of successful delivery after unexplained recurrent spontaneous ...
9746709 - Tubal occlusion failures: implications of the crest study on reducing the risk.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  14     ISSN:  0268-1161     ISO Abbreviation:  Hum. Reprod.     Publication Date:  1999 Jul 
Date Detail:
Created Date:  1999-09-13     Completed Date:  1999-09-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1875-8     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Rambam Medical Center, POB 9602, Haifa 31096 and Faculty of Medicine, Technion, Israel Institute of Technology, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Evaluation Studies as Topic
Female
Fertilization in Vitro
Gestational Age
Humans
Infant, Newborn
Ovulation Induction
Pregnancy
Pregnancy Outcome
Pregnancy Reduction, Multifetal / adverse effects,  methods*
Safety
Vagina

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The factor V Leiden mutation in Japanese couples with recurrent spontaneous abortion.
Next Document:  Maternal serum insulin-like growth factor binding protein-2 and -3 and fetal growth.